Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

NCT07816744 is registered in ClinicalTrials.gov with Axel Brandes as lead sponsor.

NCT NCT07816744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
Lead sponsor
Axel Brandes
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2030
Enrollment
480 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), obesity & overweight